linagliptin
Showing 26 - 50 of 81
Diabetes, Type 2 Trial in Worldwide (linagliptin, glimepiride, linagliptin )
Completed
- Diabetes Mellitus, Type 2
- linagliptin
- +3 more
-
Athens, Alabama
- +612 more
Dec 19, 2019
Diabetic Nephropathy Type 2 Trial in Gentofte (Linagliptin, Empagliflozin, Telmisartan)
Withdrawn
- Diabetic Nephropathy Type 2
- Linagliptin
- +3 more
-
Gentofte, DenmarkSteno Diabetes Center Copenhagen
Sep 12, 2018
Type 2-diabetes Trial in Erlangen, Nuremberg (Linagliptin, Placebo)
Completed
- Type 2-diabetes
- Linagliptin
- Placebo
-
Erlangen, Germany
- +1 more
Jan 11, 2018
Type2 Diabetes Trial in Seoul (evogliptin, Linagliptin)
Completed
- Type2 Diabetes
- evogliptin
- Linagliptin
-
Seoul, Korea, Republic ofDivision of Endocrinology and Metabolism, Department of Internal
Jul 19, 2018
Healthy Trial in Biberach (Empagliflozin, Linagliptin)
Completed
- Healthy
- Empagliflozin
- Linagliptin
-
Biberach, GermanyHumanpharmakologisches Zentrum Biberach
Jun 27, 2017
Type 2 Diabetes Trial in Prague (Exenatide, Linagliptin, Gliclazide)
Completed
- Type 2 Diabetes Mellitus
- Exenatide
- +2 more
-
Prague, CzechiaGeneral University Hospital
Feb 6, 2018
Type 2 Diabetes, Peritoneal Dialysis Trial in Guangzhou (Linagliptin, Humalog Mix 75/25)
Unknown status
- Type 2 Diabetes Mellitus
- Peritoneal Dialysis
- Linagliptin
- Humalog Mix 75/25
-
Guangzhou, Guangdong, Chinaendocrinology department of the first affiliated hospital of Sun
Oct 20, 2017
Diabetes, Type 2 Trial in Worldwide (Placebo, Linagliptin)
Completed
- Diabetes Mellitus, Type 2
- Placebo
- Linagliptin
-
Huntsville, Alabama
- +648 more
Mar 21, 2019
Diabetes, Type 2 Trial in Worldwide (Glimepiride, Metformin, Pioglitazone)
Diabetes, Type 2 Trial in Seoul (Mosapride citrate, Linagliptin, Acetaminophen (paracetamol))
Completed
- Diabetes Mellitus, Type 2
- Mosapride citrate
- +2 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Nov 27, 2017
Diabetes, Type 2 Trial in Worldwide (, linagliptin)
Completed
- Diabetes Mellitus, Type 2
- placebo
- linagliptin
-
Sheffield, Alabama
- +144 more
Jun 1, 2018
Diabetes Type 2 (T2DM), Vascular Inflammation, Plaque Morphology Trial in Aachen, Maastricht (Linagliptin, Placebo)
Terminated
- Diabetes Mellitus Type 2 (T2DM)
- +2 more
- Linagliptin
- Placebo
-
Aachen, Germany
- +1 more
Apr 10, 2017
Diabetes Trial in Neuss (Linagliptin)
Completed
- Diabetes Mellitus
- Linagliptin
-
Neuss, NRW, GermanyProfil Institut für Stoffwechselforschung GmbH
Mar 1, 2017
Diabetes Type 2 (T2DM), Left Ventricular Diastolic Dysfunction Trial in Aachen (Linagliptin, )
Terminated
- Diabetes Mellitus Type 2 (T2DM)
- Left Ventricular Diastolic Dysfunction
- Linagliptin
- placebo
-
Aachen, GermanyDepartment of Internal Medicine I, University Hospital
Apr 10, 2017
Type II Diabetes Trial in Boston (Linagliptin, Placebo, Microcirculation testing)
Completed
- Type II Diabetes Mellitus
- Linagliptin
- +4 more
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Nov 17, 2016
Ascertainment of EMR-based Clinical Covariates Among Patients
Completed
- Diabetes Mellitus, Type 2
- linagliptin
-
Boston, MassachusettsBoehringer Ingelheim Investigational Site
Dec 15, 2016
Healthy Trial in Biberach (Linagliptin, Metformin, Linagliptin/Metformin FDC)
Completed
- Healthy
- Linagliptin
- +2 more
-
Biberach, Germany1288.11.1 Boehringer Ingelheim Investigational Site
Jun 23, 2016
Healthy Trial in Ingelheim (Linagliptin, Linagliptin/Metformin ER FDC, Metformin ER)
Completed
- Healthy
- Linagliptin
- +2 more
-
Ingelheim, Germany1288.10.1 Boehringer Ingelheim Investigational Site
Jun 23, 2016
Healthy Trial in Biberach (Linagliptin/Metformin ER FDC, Linagliptin, Metformin ER)
Completed
- Healthy
- Linagliptin/Metformin ER FDC
- +2 more
-
Biberach, Germany1288.9.1 Boehringer Ingelheim Investigational Site
Jun 23, 2016
Type 2 Diabetes Trial in Groningen (Linagliptin, )
Completed
- Type 2 Diabetes Mellitus
- Linagliptin
- placebo
-
Groningen, NetherlandsUniversity Medical Center Groningen
May 17, 2016
Diabetes, Type 2 Trial in China, Malaysia, Philippines (Placebo, Linagliptin)
Completed
- Diabetes Mellitus, Type 2
- Placebo
- Linagliptin
-
Beijing, China
- +18 more
Jul 25, 2016
Diabetes, Type 2 Trial in China, Malaysia, Philippines (Linagliptin, )
Completed
- Diabetes Mellitus, Type 2
- Linagliptin
- placebo
-
Beijing, China
- +18 more
Jul 25, 2016
Diabetes, Type 2 Trial in Worldwide (Linagliptin, Empagliflozin + Linagliptin, Empaglifozin + Linagliptin )
Completed
- Diabetes Mellitus, Type 2
- Linagliptin
- +2 more
-
Gulf Shores, Alabama
- +89 more
Jun 9, 2016
Type 1 Diabetes Trial in Chandigarh (Linagliptin, Placebo)
Unknown status
- Type 1 Diabetes Mellitus
- Linagliptin
- Placebo
-
Chandigarh, IndiaDepartment of Endocrinology, PGIMER
Mar 31, 2016